Neuroprotection by Caffeine and A(2A) Adenosine Receptor Inactivation in a Model of Parkinson's Disease

類似資料

• Neuroprotection by caffeine in the MPTP model of Parkinson’s disease and its dependence on adenosine A(2A) receptors
  著者:: Xu, Kui, 等
  出版事項: (2016)
• Neuroprotection by caffeine: Time course and role of its metabolites in the MPTP model of Parkinson Disease
  著者:: Xu, Kui, 等
  出版事項: (2010)
• Dual-target-directed drugs that block monoamine oxidase B and adenosine A(2A) receptors for Parkinson’s disease
  著者:: Petzer, Jacobus P., 等
  出版事項: (2009)
• Estrogen Prevents Neuroprotection by Caffeine in the Mouse 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Model of Parkinson's Disease
  著者:: Xu, Kui, 等
  出版事項: (2006)
• Pathophysiological roles for purines: adenosine, caffeine and urate
  著者:: Morelli, Micaela, 等
  出版事項: (2010)